These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3678741

  • 1. Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy.
    Di Bisceglie AM, Waggoner JG, Hoofnagle JH.
    Gastroenterology; 1987 Dec; 93(6):1236-41. PubMed ID: 3678741
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B.
    Wood JR, Czaja AJ, Taswell HF, Ludwig J, Rakela J, Chase R.
    Gastroenterology; 1987 Dec; 93(6):1225-30. PubMed ID: 3678739
    [Abstract] [Full Text] [Related]

  • 3. Active and inactive replication of hepatitis B virus deoxyribonucleic acid in chronic liver disease.
    Yokosuka O, Omata M, Imazeki F, Okuda K.
    Gastroenterology; 1985 Sep; 89(3):610-6. PubMed ID: 4018503
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B virus DNA and e antigen in serum from blood donors in the United Kingdom positive for hepatitis B surface antigen.
    Harrison TJ, Bal V, Wheeler EG, Meacock TJ, Harrison JF, Zuckerman AJ.
    Br Med J (Clin Res Ed); 1985 Mar 02; 290(6469):663-4. PubMed ID: 3918707
    [Abstract] [Full Text] [Related]

  • 5. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
    Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, Callea F, Verme G.
    Gastroenterology; 1986 May 02; 90(5 Pt 1):1268-73. PubMed ID: 3956945
    [Abstract] [Full Text] [Related]

  • 6. Presence of hepatitis B virus-deoxyribonucleic acid in human tissues under unexpected circumstances.
    Shafritz DA.
    Gastroenterology; 1985 Sep 02; 89(3):687-90. PubMed ID: 4018508
    [No Abstract] [Full Text] [Related]

  • 7. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
    Ranki M, Schätzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P.
    Hepatology; 1995 Jun 02; 21(6):1492-9. PubMed ID: 7768492
    [Abstract] [Full Text] [Related]

  • 8. Markers of viral replication in patients with chronic hepatitis B virus infection.
    Govindarajan S, Fong TL, Valinluck B, Edwards V, Redeker AG.
    Am J Clin Pathol; 1988 Feb 02; 89(2):233-7. PubMed ID: 3341283
    [Abstract] [Full Text] [Related]

  • 9. Interferon alfa therapy in patients with chronic hepatitis B virus infection. Effects on hepatitis B virus DNA in the liver.
    Lok AS, Ma OC, Lau JY.
    Gastroenterology; 1991 Mar 02; 100(3):756-61. PubMed ID: 1993497
    [Abstract] [Full Text] [Related]

  • 10. Correlation Between Quantitative Hepatitis B Surface Antigen and Hepatitis B Virus Deoxyribonucleic Acid Levels in Hepatitis B e Antigen-Positive and Hepatitis B e AntigenNegative Chronic Hepatitis B Patients.
    Nirmala VFI, Aryati A, Susianti H, Mustika S.
    Turk J Gastroenterol; 2023 Apr 02; 34(4):378-382. PubMed ID: 37089049
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Different levels of hepatitis B virus replication among hepatitis Be antigen-positive chronic carriers.
    Bartolomé J, Castillo I, Mora I, Gutiez J, Porres JC, Carreño V.
    Acta Virol; 1988 May 02; 32(3):193-7. PubMed ID: 2902767
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The natural history of asymptomatic hepatitis B surface antigen carriers.
    de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, Donato MF, Ronchi G.
    Ann Intern Med; 1993 Feb 01; 118(3):191-4. PubMed ID: 8417636
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.
    Lai CL, Ching CK, Tung AK, Li E, Young J, Hill A, Wong BC, Dent J, Wu PC.
    Hepatology; 1997 Jan 01; 25(1):241-4. PubMed ID: 8985298
    [Abstract] [Full Text] [Related]

  • 18. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R.
    Liver Transpl; 2001 Feb 01; 7(2):113-7. PubMed ID: 11172394
    [Abstract] [Full Text] [Related]

  • 19. Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis.
    Sjogren M, Hoofnagle JH.
    Gastroenterology; 1985 Aug 01; 89(2):252-8. PubMed ID: 4007416
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.